High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas
about
Isolated clonal cytogenetic abnormalities after high-dose therapy.Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia.Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients.Changes in T lymphocyte subsets in mice with CT26 colon tumors after treatment with donor lymphocyte infusion.
P2860
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
High-dose cyclophosphamide and ...... rmed and mantle cell lymphomas
@ast
High-dose cyclophosphamide and ...... rmed and mantle cell lymphomas
@en
type
label
High-dose cyclophosphamide and ...... rmed and mantle cell lymphomas
@ast
High-dose cyclophosphamide and ...... rmed and mantle cell lymphomas
@en
prefLabel
High-dose cyclophosphamide and ...... rmed and mantle cell lymphomas
@ast
High-dose cyclophosphamide and ...... rmed and mantle cell lymphomas
@en
P2093
P2860
P1433
P1476
High-dose cyclophosphamide and ...... rmed and mantle cell lymphomas
@en
P2093
Carol Ann Huff
Douglas E Gladstone
Ephraim Fuchs
Hyam Levitsky
Ivan Borrello
Javier Bolaños-Meade
Jonathan Powell
Leo Luznik
Lode J Swinnen
Marianna Zahurak
P2860
P304
P356
10.3109/10428194.2011.594191
P577
2011-07-14T00:00:00Z